United States · FDA National Drug Code directory
ETOPOPHOS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61269-410_ef45c859-64fd-4af8-a207-d1048bf7049b
- Product NDC
- 61269-410
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- etoposide phosphate
- Labeler
- H2-Pharma, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090601
- Source listing expiry
- 20271231
Source-listed ingredients
- ETOPOSIDE PHOSPHATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61269-410-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · 61269-410-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →